42. Larosa JA, Ahmad N, Feinberg M, Shah M, Dibrienza R, Studer S. The use of an early alert system to improve compliance with sepsis bundles and to assess impact on mortality. Crit Care Res Pract. 2012;2012:980369. 43. Gatewood MO, Wemple M, Greco S, Kritek PA, Durvasula R. A quality improvement project to improve early sepsis care in the emergency department. BMJ Qual Saf. 2015;24(12):787- 795. 44. Centers for Disease Control and Prevention. What is C. diff? https://www.cdc.gov/cdiff/ what-is.html. Accessed October 15, 2021. 45. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198-1208. 46. Zhang D, Prabhu VS, Marcella SW. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States. Clin Infect Dis. 2018;66(9):1326- 1332. 47. Luo R, Barlam TF. Ten-year review of Clostridium difficile infection in acute care hospitals in the USA, 2005-2014. J Hosp Infect. 2018;98(1):40-43. 48. Centers for Disease Control and Prevention. Core elements of hospital antibiotic stewardship programs. https://www.cdc.gov/ antibiotic-use/core-elements/hospital.html. Accessed October 17, 2021. 49. Ticinesi A, Nouvenne A, Folesani G, et al. Multimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS). BMJ Open. 2015;5(10):e009316. 50. Centers for Disease Control and Prevention. Projected incidence of infections and deaths due to antibiotic resistant healthcare- associated infections. https://www.cdc.gov/ hai/data/archive/stop-spread-technical- appendix.html. Accessed October 16, 2021. 51. Centers for Disease Control and Prevention. Data summary of HAIs in the U.S.: Assessing progress 2006-2016. https:// www.cdc.gov/hai/data/archive/data- summary-assessing-progress.html?CDC_ AA_refVal=https%3A%2F%2Fwww.cdc. gov%2Fhai%2Fsurveillance%2Fdata- reports%2Fdata-summary-assessing- progress.html. Accessed October 16, 2021. 52. Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(7):1748-1754. 53. Shea KM, Hobbs ALV, Jaso TC, et al. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection. Antimicrob Agents Chemother. 2017;61(6).
54. Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum beta-lactamase- producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2013;41(2):137-142. 55. Talpaert MJ, Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66(9):2168-2174. 56. Yam P, Fales D, Jemison J, Gillum M, Bernstein M. Implementation of an antimicrobial stewardship program in a rural hospital. Am J Health Syst Pharm. 2012;69(13):1142-1148. 57. McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1-e48. 58. Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol. 2009;30(10):939- 944. 59. Bearman G, Rosato AE, Duane TM, et al. Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2010;31(5):491-497. 60. Landelle C, Verachten M, Legrand P, Girou E, Barbut F, Brun-Buisson C. Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol. 2014;35(1):10-15. 61. Erasmus V, Daha TJ, Brug H, et al. Systematic review of studies on compliance with hand hygiene guidelines in hospital care. Infect Control Hosp Epidemiol. 2010;31(3):283- 294. 62. Sunkesula VC, Knighton S, Zabarsky TF, Kundrapu S, Higgins PA, Donskey CJ. Four Moments for Patient Hand Hygiene: A Patient- Centered, Provider-Facilitated Model to Improve Patient Hand Hygiene. Infect Control Hosp Epidemiol. 2015;36(8):986-989. 63. Tomas ME, Sunkesula VC, Kundrapu S, Wilson BM, Donskey CJ. An intervention to reduce health care personnel hand contamination during care of patients with Clostridium difficile infection. Am J Infect Control. 2015;43(12):1366-1367. 64. Trick WE, Lin MY, Cheng-Leidig R, et al. Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA. Emerg Infect Dis. 2015;21(10):1725-1732.
65. Centers for Disease Control and Prevention. Containing unusual resistance https://www. cdc.gov/vitalsigns/pdf/2018-04-vitalsigns.pdf. Accessed October 30, 2021. 66. Duszynska W, Adamik B, Lentka-Bera K, et al. Effect of universal chlorhexidine decolonisation on the infection rate in intensive care patients. Anaesthesiol Intensive Ther. 2017;49(1):28- 33. 67. Wittekamp BH, Plantinga NL, Cooper BS, et al. Decontamination Strategies and Bloodstream Infections With Antibiotic- Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial. JAMA. 2018;320(20):2087-2098. 68. Centers for Disease Control and Prevention. Interim guidance for a public health response to contain novel or targeted multidrug- resistant organisms. https://www.cdc.gov/hai/ pdfs/containment/Health-Response-Contain- MDRO-H.pdf. Accessed October 30, 2021. 69. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45(8):992-998. 70. Wilcox MH, Fawley WN. Hospital disinfectants and spore formation by Clostridium difficile. Lancet. 2000;356(9238):1324. 71. Fawley WN, Underwood S, Freeman J, et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol. 2007;28(8):920-925. 72. Levin J, Riley LS, Parrish C, English D, Ahn S. The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital- associated Clostridium difficile infection in a community hospital. Am J Infect Control. 2013;41(8):746-748. 73. Oldfield EI, Oldfield EC, III, Johnson DA. Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J Gastrointest Pharmacol Ther. 2014;5(1):1- 26. 74. Power M, Wigglesworth N, Donaldson E, Chadwick P, Gillibrand S, Goldmann D. Reducing Clostridium difficile infection in acute care by using an improvement collaborative. BMJ. 2010;341:c3359. 75. Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011- 2014. Infect Control Hosp Epidemiol. 2016;37(11):1288-1301. 76. Patel PK, Gupta A, Vaughn VM, Mann JD, Ameling JM, Meddings J. Review of Strategies to Reduce Central Line-Associated Bloodstream Infection (CLABSI) and Catheter-Associated Urinary Tract Infection (CAUTI) in Adult ICUs. J Hosp Med. 2018;13(2):105-116.
114
Powered by FlippingBook